Breast Cancer
FY22 Breakthrough Award - Funding Level 3 - Clinical Trial
The list of Fiscal Year 2022 Breast Cancer Research Program Breakthrough Award - Funding Level 3 - Clinical Trial applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
MBQ Pharma, Inc. | Jose Rodriguez |
Last updated Friday, December 2, 2022